相关实验视频
Updated: Jul 16, 2026
02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
概括
在服用单氨酸氧化酶抑制剂 (MAOI) 的患者中,阿米特利普提林显著降低了对提拉胺的压力反应. 这种组合可能会对富含胺的食物提供保护,但仍建议谨慎.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 临床医学 临床医学
背景情况:
- 单氨酸氧化酶抑制剂 (MAOI) 与危险的高血压反应有关,这些高血压反应与富含提拉胺的食物有关.
- 三环抗抑郁药 (TCA) 如阿米特里普提林,多提和三胺通常被处方.
- 关于提拉胺敏感性的TCAs和MAOI之间的相互作用需要进一步阐明.
研究的目的:
- 调查不同三环抗抑郁药 (阿米特利普提林,多提,三胺) 对接受单氨酸氧化酶抑制剂 (MAOI) 患者的提拉胺压力反应的影响.
- 评估将阿米特利普提林与MAOI结合用于减轻胺诱导的高血压危机的潜力.
主要方法:
- 接受MAOI治疗的患者被静脉注射提拉胺.
- 对提拉胺的压力器反应在阿米特利普提林,多提或三胺的使用前后被测量.
主要成果:
- 在接受MAOI治疗的患者中,阿米林显著降低了静脉注射蒂拉明的压力反应.
- 在这个患者群体中,多西平和三胺对提拉胺敏感性的影响很小.
- 阿米特利普提林和MAOI的组合,以适度剂量开始并逐渐增加,可能会对含胺的食物提供保护.
结论:
- 阿米特利普提林在接受MAOI治疗的患者中显示出对提拉胺诱导的压力反应的保护作用.
- 虽然阿米林可能会降低风险,但服用MAOI的患者仍应避免因潜在的全身吸收而食用富含氨酸的食物.
- 对联合阿米和MAOI治疗的最佳剂量策略进行进一步研究是有必要的.
相关概念视频
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...